Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.3205
+0.0035 (1.10%)
May 5, 2025, 4:00 PM EDT - Market closed
Rallybio Market Cap
Rallybio has a market cap or net worth of $13.34 million as of May 5, 2025. Its market cap has decreased by -81.72% in one year.
Market Cap
13.34M
Enterprise Value
-52.17M
1-Year Change
-81.72%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $13.34M, a decrease of -96.71%. That is a compound annual growth rate of -59.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 13.19M | -66.88% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |